HR Execs on the Move

Sourcepass

www.sourcepass.com

 
Sourcepass is digitizing the way small and mid-sized businesses (SMB) access innovative IT solutions by making strategic acquisitions in the IT Managed Services space. Sourcepass is committed to eliminating the challenges that SMBs face worldwide, allowing them to focus on their core business. In most companies IT decisions become a huge distraction as they can be cost prohibitive. The Sourcepass culture promotes modernization, diversification, and productivity to deliver world-class IT results and drive growth. Their goal is to help SMBs successfully navigate the digital era and remain competitive against a shifting technology landscape by providing relevant solutions like remote workforce, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Noelle Hunter
 Vice President of Sales Profile
Chuck Canton
 Founder and Executive Chairman Profile

Similar Companies

Government Services

Eagle Integrated Services is an SBA certified 8(a) Small Disadvantaged Business and Alaska Native Corporation (ANC) that provides Health Information Systems, Program Management, Engineering and Technical Support, Data Analytics, Cybersecurity, Risk Man...

Trada

Trada is a Boulder, CO-based company in the Software and Internet sector.

Caveon Test Security

Caveon Test Security offers solutions for test programs, from developing secure exams to protecting existing exams to responding to security breaches.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.

Griky

Organizamos el conocimiento del mundo en listas de aprendizaje para compartirlas con millones de personas. Griky es el futuro de la educación, HOY.